Cerami, Chiara <br/><br/>
Clinical validity of delayed recall tests as a gateway biomarker for Alzheimer's disease in the context of a structured 5-phase development framework.  [electronic resource] 

 -  Neurobiology of aging  04 2017 
 - 153-166 p.  digital 
<br/><br/> Publication Type: Journal Article; Review; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1558-1497 
<br/><br/><label>Standard No.: </label>10.1016/j.neurobiolaging.2016.03.034  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Alzheimer Disease--diagnosis<br/>Biomarkers--analysis<br/>Cognitive Dysfunction--diagnosis<br/>Cues<br/>Early Diagnosis<br/>Humans<br/>Memory, Episodic<br/>Mental Recall<br/>Neuropsychological Tests<br/>Reproducibility of Results<br/>Temporal Lobe--physiopathology